Cargando…
Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation
Glioblastoma (GBM) is the most common and malignant type of primary brain tumor and associated with a devastating prognosis. Signal transducer and activator of transcription number 3 (STAT3) is an important pathogenic factor in GBM and can be specifically inhibited with Stattic. Metformin inhibits G...
Autores principales: | Leidgens, Verena, Proske, Judith, Rauer, Lisa, Moeckel, Sylvia, Renner, Kathrin, Bogdahn, Ulrich, Riemenschneider, Markus J., Proescholdt, Martin, Vollmann-Zwerenz, Arabel, Hau, Peter, Seliger, Corinna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352398/ https://www.ncbi.nlm.nih.gov/pubmed/28030813 http://dx.doi.org/10.18632/oncotarget.14159 |
Ejemplares similares
-
Heterogeneity of Amino Acid Profiles of Proneural and Mesenchymal Brain-Tumor Initiating Cells
por: Seliger, Corinna, et al.
Publicado: (2023) -
ATF4 contributes to autophagy and survival in sunitinib treated brain tumor initiating cells (BTICs)
por: Moeckel, Sylvia, et al.
Publicado: (2019) -
Combined Modulation of Tumor Metabolism by Metformin and Diclofenac in Glioma
por: Gerthofer, Valeria, et al.
Publicado: (2018) -
Metabolic Heterogeneity of Brain Tumor Cells of Proneural and Mesenchymal Origin
por: Seliger, Corinna, et al.
Publicado: (2022) -
Validation Study: Response-Predictive Gene Expression Profiling of Glioma Progenitor Cells In Vitro
por: Moeckel, Sylvia, et al.
Publicado: (2016)